Problem: Placental pericytes are essential for placental microvascular function, stability, and integrity. Mechanisms of human cytomegalovirus (HCMV) pathogenesis incorporating placental pericytes are unknown.
components of the capillaries and post-capillary venules abluminal to microvascular endothelial cells. 15, 16 The retina and brain have the highest density of vascular pericytes in the body. 17 Wilkerson et al. 18 recently reported that primary human retinal vascular pericytes are fully permissive for HCMV infection and that retinal pericytes are more permissive for HCMV lytic replication compared to retinal microvascular endothelial and Mϋller cells. They concluded that retinal pericytes likely serve as amplification reservoirs disseminating through the inner retinal barrier. Retinal pericyte exposure to a clinical strain of HCMV resulted in dysregulation of proinflammatory angiogenic cytokines. 18 Similar findings were observed with brain pericytes. 19 Human cytomegalovirus placental pathogenesis models that include placental pericytes have not been reported. The signaling mechanisms between placental pericytes, cytotrophoblast, and villous fibroblasts are largely unknown. 20 This is the first report investigating the infectivity of human placental pericytes for HCMV, their potential role in viral dissemination in placental tissue, and the implications for HCMV-associated congenital disease.
| MATERIALS AND METHODS

| Placental collection and trophoblasts isolation
Human cytomegalovirus-negative placentas were obtained from elective non-laboring cesarean sections after uncomplicated fullterm pregnancies at Vanderbilt University Medical Center. These studies were approved by the Vanderbilt University Institutional Review Board. HCMV status was verified by immunochemistry (IHC). 21 For cytotrophoblast isolation, placental nodes (cotyledon) were washed 3× with phosphate buffered saline (PBS), excised, and the decidual layer removed to expose villous tissue. Nodes were minced with a number 21 scalpel and individual 5 mm explants were spatially added to 100×20 mm dishes and cultured in trophoblast medium (ScienCell 10% fetal bovine serum, 1% penicillin/streptomycin, Carlsbad, CA, USA). Trophoblast medium was supplemented with 25 μg/mL of Fungizone (Gibco, Life Technologies, Grand Island, NY, USA). Explant trophoblast outgrowth was determined by microscopy. Cytotrophoblast colonies were isolated by trypsinization (0.05% trypsin/EDTA (Gibco, Life Technologies) for 10 minutes at 37°C) using cloning cylinders. Trypsinized cytotrophoblast were added to 4-well chamber slides containing trophoblast medium. Confluent cells were confirmed as trophoblasts by cytokeratin-7 staining (Millipore, Bedford, MA, USA).
| Placental tissue
IRB-approved placental tissues were obtained via collaboration with Dr. Ravit Boger at the Johns Hopkins University Medical
Center. Disseminated cytomegalovirus infection in placental tissue was confirmed by a pathologist and subsequently reconfirmed by IHC staining for the HCMV major immediate early (MIE) proteins. 22 Tissue was formalin fixed and paraffin embedded, and 5-micron sections were placed on chemate slides for dual-labeled IHC staining. 21 
| Cells and viruses
The primary isolate (termed SBCMV) was provided by Dr. Ravit
Arav-Boger, Johns Hopkins University and obtained from the urine of a congenitally infected infant with disseminated HCMV disease.
Institutional review board (IRB) exemption for the use of this isolate was given by Johns Hopkins Hospital. 19 The HCMV-GFP recombinant virus was obtained from Dr. Gary Hayward, Johns Hopkins University.
All infections with SBCMV clinical strain were performed at passage respectively. Heat-killed SBCMV was prepared by heating the inoculum to 65°C for 30 minutes in a water bath. 23 The mild heat inactivation that we employ is unlikely to cause a global effect on thermolabile viral proteins.
| Immunohistochemistry
Archived placental tissue was dual-label IHC stained for HCMV-MIE, cytokeratin-7, cluster designation 3 T-cell marker (CD3; T-cell marker), and cluster designation 68 macrophage marker (CD68; macrophage marker) as previously described. 21 The placenta tri-cell culture was dual-labeled for antigenic biomarkers cytokeratin-7 (clone OV-TL 12/30, Millipore, Bedford, MA, USA) and cluster of differentiation 31 (CD31; Millipore) as previously described. 18, 19 Substrates for IHC were diaminobenzidine (blue color) and alkaline phosphatase (red color). Placental fibroblasts were unstained.
| Cytomegalovirus infection of pericytes, cytotrophoblasts, and villous fibroblasts
Cytomegalovirus infection and RNA isolation have been previously described. 19 The SBCMV clinical isolate, Toledo lab-adapted strain of HCMV, and HCMV-GFP recombinant virus were cultivated in human foreskin fibroblasts. Placenta pericytes, cytotrophoblasts, and villous fibroblasts were infected at a multiplicity of infection (MOI) of 0.1.
Virus adsorption was allowed for 2 hours, and the infectious inoculum was replaced with fresh medium. Mock-infected cells included medium only with no virus. 
| Immunofluorescence
| Tri-cell placenta model
The placental tri-cell culture model, composed of primary pericytes, cytotrophoblasts, and villous fibroblasts, was established in chamber slides at a ratio of 1:2:2, respectively. The rationale for the 1:2:2 ratio supports the finding that pericyte density (with the exception of the brain and retina) is found to be lower in other vascular beds. However, the pericyte cell density associated with the placental vasculature is unknown.
Initial cell cultivations were performed with medium recommended by the manufacturer. Pericytes were initially cultivated in complete PM and allowed to become confluent at cell density 2.5×10
5
. Cytotrophoblasts, initially cultivated at the same cell density in trophoblast medium (ScienCell), were added and the mixture cultivated in PM. After 48 hours, villous fibroblasts cultivated in fibroblast medium at the same cell density were added to complete the tri-cell mixture with all three cell types growing in PM. The tri-cell mixture was then infected for 24 hours with SBCMV at a MOI of 0.1. The tricell mixture was stained for live/dead cell viability using an assay kit (Life Technologies).
| Luminex analysis
The inflammatory and angiogenic cytokine analysis was performed with 200 μL of supernatant from three pooled cultures of mockinfected, SBCMV-infected, and SBCMV heat-killed placental pericytes 24 hours post-exposure using a Luminex instrument (Luminex Corporation, Austin, TX, USA) and 100-plate viewer software.
Luminex analysis was performed on supernatants as previously described. 24 Infections were performed in triplicate in chamber slides for 24, 48, 72, and 96 hours post-infection. Replicate assays are inherent in the Luminex technology by counting 50 bead replicates per analyte and reporting the median. This is the equivalent of running 50 replicate assays per well. In addition, robotic pipetting was performed for all volume-critical steps, which minimizes well-to-well variability, and calibrators and controls were run in duplicate involving three levels of control per analyte in duplicate on every plate.
| Virus replication
For virus replication, kinetics are the averages of triplicate samples performed in multiwell chamber slides as previously described. 18 
| RESULTS
| HCMV replication is enhanced in the villous core of placenta in vivo
Using dual-labeled IHC, for cytokeratin-7 to stain trophoblasts brown and HCMV-MIE to stain HCMV-infected cells red, we examined archival placental tissue from a neonate with disseminated HCMV disease and observed focal infection initially in syncytiotrophoblasts ( Figure 1A ). On the same slide, we observed virus in the underlying cytotrophoblast layer ( Figure 1B ) and increased viral replication in the F I G U R E 1 Paraffin-embedded placental tissue from neonates infected with CMV dual stained by IHC for cytotrophoblasts with cytokeratin-7 (brown) antibody and CMV with antibodies to the major immediate early genes (MIE), (red). Black arrows show HCMV-infected cells staining red. Scale bar=100 μm
HCMV Entry via Infection of Cytotrophoblasts and Dissemination in the Villous Core by Dual-Labeled IHC (A) (B) (C)
villous core region ( Figure 1C ), which agrees with normal HCMV dissemination in the villous core. Infected cells are identified using black arrows.
| HCMV induces T-cell/macrophage infiltrate at the site of infection in vivo
Using dual-label IHC staining for the T-cell biomarker CD3 (brown/ white arrows) and the HCMV-MIE for HCMV-infected cells (red/black arrows) in archival tissue from the placenta depicted in Figure 1 , we observed T-cell infiltration localized at the site of infection, indicated
by HCMV-infected cells staining red (designated by black arrows in Figure 2A ,B). We stained for the macrophage antigenic biomarker CD68 and observed infiltrate at the site of infection (designated by white arrows in Figure 2C ,D).
| Placental pericytes, cytotrophoblasts, and villous fibroblasts are fully permissive for HCMV infection
Normal placental pericytes, cytotrophoblasts, and villous fibroblasts had morphological characteristics similar to their respective cell types, as previously observed ( Figure 3 ). Placental pericytes, cytotrophoblasts, and villous fibroblasts stained positive for known antigenic biomarkers SMA, cytokeratin-7, and vimentin, respectively (Figure 3A-C).
All three cell types showed characteristic HCMV cytopathology after 5 days post-infection with the Toledo lab-adapted strain of HCMV, and 7 days post-infection with SBCMV ( Figure 3A-C) . All cell types expressed both the major immediate early and the pp65 late protein by immunofluorescent staining. 25 Pericytes also expressed the pp28 late antigen (insert Figures 3A-7) . All cell types supported lytic Primary human placental pericytes and CMV infection 
Primary human cytotrophoblasts are permissive for CMV infection
| Proinflammatory and angiogenic cytokines are induced in SBCMV-infected placental pericytes
Dysregulation of proinflammatory and angiogenic cytokines plays a major role in HCMV placental pathology. 26, 27 We examined 24 hours supernatants from SBCMV-infected primary human placental pericytes along with mock-infected cells and cells exposed to heatkilled virus for changes in secretion profiles using Luminex assays (Figure 4) . We observed increased monocyte chemotactic protein-1 (MCP-1) secretion by pericytes exposed to SBCMV and a marginal increase in MCP-1 from cells exposed to heat-killed virus, relative to mock-infected cells ( Figure 4A ). The highest level of MCP-1 secretion was observed from pericytes exposed to replication competent virus ( Figure 4A ). High levels of vascular endothelial cell growth factor (VEGF) were observed in supernatant from pericytes exposed to SBCMV and heat-killed virus compared to mock-infected cells ( Figure 4B ), and equal levels of VEGF were observed from SBCMVinfected and heat-killed virus exposed pericytes. There was a marginal increase in interleukin-8 (IL-8) levels from SBCMV-infected pericytes compared to mock-infected cells and a reduction of IL-8 from heat-killed virus exposed pericytes ( Figure 4C ). There was an increase in RANTES/CCL5 from SBCMV-infected pericytes compared to heatkilled virus exposed pericytes and mock-infected cells ( Figure 4D ).
Regulated upon activation normal T-cell expressed and presumably
secreted (RANTES) levels were equal for heat-killed virus exposed pericytes and mock-infected cells. We observed reduced levels of the proinflammatory cytokine interleukin-6 (IL-6) from both SBCMVinfected and heat-killed exposed pericytes compared to uninfected controls ( Figure 4E ). The greatest reduction occurred in cultures exposed to heat-killed virus. We observed no significant change in matrix metalloproteinase-9 (MMP9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) ( Figure 4F ,G) levels.
| Placental pericytes are more permissive for HCMV infection compared to cytotrophoblasts and villous fibroblasts
Individual cellular components of the placenta tri-cell mixture were compared to determine their infectivity when exposed to HCMV-GFP. 
| Dysregulation of proinflammatory and angiogenic cytokines in a tri-cell model of the SBCMVinfected placenta
Supernatant from the placental tri-cell culture cultivated in PM only was exposed to SBCMV, heat-killed SBCMV, and medium only (mockinfected) and examined by Luminex assay at 24 hours post-infection ( Figure 6 ). We observed higher levels of MCP-1, RANTES, IL-6, and cultures. Tri-cell cultures exposed to heat-killed virus showed higher levels of MMP9 compared to those exposed to SBCMV.
We examined placental tissue dual-labeled IHC from a child with congenital HCMV infection in utero and observed disseminated HCMV in the placenta villous ( Figure 7A ). We demonstrate dual-labeled pericytes stained dark purple and positive for HCMV-MIE antigen stained brown ( Figure 7B ).
| CONCLUSION
To our knowledge, this is the first report that demonstrates placental pericyte permissiveness for HCMV infection and identifies them as the most permissive cell type in the villous stroma relative to trophoblasts 23,28 and villous fibroblasts. The results from these studies support our previous work showing that pericytes in vascular beds of the blood brain barrier and the inner blood retinal barrier (IBRB) that are the most permissive cellular targets for HCMV primary infection. 18, 19 Expression profiles of primary cells can change in culture; therefore, it is essential that tri-cell culture infection models be established using primary cells at low passage, and infections with clinical strains at low MOI, to better approximate clinical conditions.
We observe HCMV induction of T-cell/macrophage infiltrates at the site of infection in vivo. Pereira et al. 29 finds that macrophages within the villous stroma contain cytoplasmic vesicles with viral structural proteins which argues that macrophages can restrict virus repli- In addition, there are contrasting findings from a number studies regarding HCMV infection and replication in syncytiotrophoblasts.
31
Some studies suggest that syncytiotrophoblast does not support HCMV infection and replication. Studies using first trimester placental tissue explants, maintained either as primary histocultures or after culture on matrigel, and syncytiotrophoblasts were found be only rarely infected by HCMV. 32, 33 A number of studies support HCMV infection and replication in syncytiotrophoblasts. 31, 34, 35 A study by Schleiss et al. 31 showed that syncytiotrophoblast cells could support productive HCMV infection in vitro by dual expression of IE72 immediate early protein, and the late HCMV structural protein, pp65 (ppUL83).
These differences in syncytiotrophoblasts permissiveness for HCMV infection and replication could be the result of culturing procedures, differences in the gestational age of the placental tissue as well as differences in the expression profile of HCMV receptors between syncytiotrophoblasts and cytotrophoblasts.
36,37
Our examination of the secretion profile of placental pericytes alone at 24 hours post-exposure to SBCMV revealed increased expression of MCP-1. Hamilton et al., 38 using ex vivo placental histocultures infected with laboratory and clinical HCMV, also showed increased MCP-1. They suggested that HCMV infection alters the placental microenvironment and proposed that MCP-1 initiates placental and fetal injury. 38 We observed increased levels of VEGF in supernatants of placental pericytes exposed to SBCMV (Figure 4 ). Studies have found increased levels of soluble VEGF/VEGF receptor-1 in supernatants taken from preeclamptic placental explants, implicating placental VEGF/VEGF receptor-1 in the inhibition of angiogenesis in pre-eclampsia. 39 We observed a marginal increase in the levels of RANTES exclusively in SBCMVexposed pericytes. Recent studies also showed increased RANTES/ CCL5 expression in brain vascular pericytes exposed to HCMV. 18 We also showed that IL-6 levels for both SBCMV-infected pericytes and heat-killed virus were lower compared to mock-infected pericytes.
Other investigators found that IL-6 levels were suppressed in human fibroblasts undergoing active infection mediated in part by HCMV IE2
protein and post-transcriptional destabilization of IL-6 mRNA.
40
The secretion profile of the placental tri-cell mixture at 24 hours post-exposure to SBCMV revealed increased expression of MCP-1
and no significant change in VEFG or IL-8. However, we saw increased levels of RANTES, IL-6, and TIMP-1 ( Figure 6 ). Finally, lower levels of MMP9 were observed with the lowest occurring in SBCMV-infected cells ( Figure 6 ). This finding correlates with increased levels of TIMP-1 observed in the SBCMV-exposed tri-cell mixture. HCMV infection of placental pericytes is a lytic infection that would result in pericyte loss at proximal sites within the placental vasculature. This would have implications for placental vascular permeability and would support an increase in placental inflammation and angiogenesis as well as impaired tissue perfusion and microcirculatory abnormalities. In previous studies in which retinal pericytes alone were exposed to SBCMV after 24 hours, we observed lower levels of MMP9, IL-6, and TIMP-1 when compared to placental pericytes exposed alone to SBCMV. 18 However, in both retinal and placental pericytes exposed to SBCMV at 24 hours we observed higher levels of RANTES when compared to both mock-infected and heat-killed virus controls, as well as higher levels of IL-8 in SBCMV and heat-killed virus exposed pericytes compared to mock-infected controls. 18 The eye and placenta represent vastly different microenvironments trafficked by HCMV that will likely influence cytokine/chemokine expression profiles during infection.
We acknowledge the limitations of the 24-hour time interval; however, cytokine profiles can be unstable over time, and our intention was to examine early events triggered by HCMV during the course of infection. We are also aware that the marginal changes observed in the the system could be easily adapted to study other abnormalities, including IUGR, pre-eclampsia, and diabetic placenta, and the effects of potential toxins. 41 
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